Insider · CIK 0001997460
Joel Latham
Files at IXHL (Incannex Healthcare Inc.). First filing -, latest -.
In brief
Joel Latham files SEC Form 4 as CEO, president and director at IXHL (Incannex Healthcare Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joel Latham has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | IXHL Incannex Healthcare Inc. | AGrant or award Common Stock, $0.0001 par value per share | +22,608,692 | $0.00 | $0 | 24,186,177 | Nov 14, 2025 |
| Dec 21, 2023 | IXHL Incannex Healthcare Inc. | AGrant or award Common Stock | +1,340,000 | $0.00 | $0 | 1,577,485 | Dec 21, 2023 |
Questions about Joel Latham
Answered from the filings on this page, as of the latest one.
Is Joel Latham buying or selling?
Joel Latham has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joel Latham's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joel Latham has 0.
Where does Joel Latham file Form 4?
Joel Latham has filed Form 4 at IXHL (Incannex Healthcare Inc.) as CEO and President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.